Skip to main content
. Author manuscript; available in PMC: 2011 Jul 15.
Published in final edited form as: J Immunol. 2010 Jun 11;185(2):1103–1113. doi: 10.4049/jimmunol.0902895

FIGURE 5.

FIGURE 5

pJAK2(1001–1013) inhibits vaccinia virus replication in a dose-dependent manner as determined by a one-step growth curve. BSC-40 cells were grown to confluency and left untreated or treated with the indicated amounts of lipo-pJAK2(1001–1013) or the alanine-substituted control peptide for 1 h. Cells were next infected with vaccinia virus at an moi of 5. After 1 h, the cells were washed and incubated in the presence of the same concentrations of peptides for 1 d. Supernatant and cell extracts obtained were titrated for the amount of intracellular (A) and extracellular (B) virus, respectively.